when to stop tirzepatide before surgery Weight Loss Medications do you need to stop

Speaking with Dr

Review discussing glycines role as a substrate for glutathione synthesis and antioxidant support

2021 Mar 27;9(2):71

14-16 For patients receiving either a GLP-1 RA or an SGLT2 inhibitor for CV risk reduction, the ADA recommends considering the addition of the other class if benefits outweigh risks (e.g., if already on a GLP-1 RA, add an SGLT2 inhibitor with proven CV benefit or vice versa) in addition to optimizing other guideline-directed medical therapies for prevention ( Figure 4 )

Pharmacotherapy, including semaglutide 2.4 mg and liraglutide 3 mg, offers a treatment option for weight management